23andMe is launching a new product, Total Health, which allows customers to sequence their entire exome to better understand and manage health risks hidden in their DNA. The service, available for $1,188 a year, also connects customers to health-care practitioners and provides biannual blood tests. This move is part of 23andMe's transition from a consumer DNA-testing company to a healthcare company.